Pharmaceuticals

Insomnia Therapeutics Market Forecast 2025–2034: Where Businesses Should Invest Next

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Insomnia Therapeutics Market Between 2025 And 2029?

The insomnia therapeutics market size has experienced substantial expansion recently. It is set to increase from $3.03 billion in 2024 to $3.2 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.7%. This historical progression is largely due to the rising occurrence of insomnia, enhanced understanding of sleep disorders, greater acceptance of cognitive behavioral therapy for insomnia (CBT-I), broader availability of pharmaceutical remedies, and increased consumption of over-the-counter sleep aids.

The insomnia therapeutics market is projected to experience substantial expansion in the coming years. It is anticipated to reach $3.98 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.6%. This anticipated growth during the forecast period can be primarily attributed to several factors, including breakthroughs in AI-powered sleep monitoring, a rising need for individualized medicine, an expanding elderly demographic experiencing sleep disorders, greater public awareness of mental health issues, and a widening array of new insomnia medications under development. Key trends expected during this period encompass the incorporation of digital therapeutics into insomnia management, an increasing inclination towards non-drug-based treatments, wider uptake of wearable devices for sleep tracking, the evolution of advanced sleep medications, and the expansion of telemedicine services for addressing sleep disorders.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24255&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Insomnia Therapeutics Industry?

Future expansion of the insomnia therapeutics market is anticipated, driven by escalating stress levels and evolving lifestyle patterns. These shifts encompass psychological and behavioral alterations in daily routines and obligations, which often lead to emotional pressure and interrupted sleep cycles. A primary cause of these escalating stress levels and changes in lifestyle is continuous digital connectivity, blurring work-life distinctions and restricting periods for genuine mental recuperation. Insomnia therapeutics serves a vital function by providing effective, scientifically supported treatments designed to re-establish healthy sleep, alleviate anxiety associated with sleep, and foster mental well-being in the presence of contemporary stressors. For example, data from May 2024, released by the American Psychiatric Association (APA), a US-based organization of psychiatrists, indicated a growing percentage of U.S. adults experiencing increased anxiety, climbing from 32% in 2022 to 37% in 2023, and further to 43% in 2024. Consequently, the escalating stress levels and evolving lifestyle behaviors are indeed fueling the expansion of the insomnia therapeutics market.

What Are The Major Segment Types Covered In The Insomnia Therapeutics Market?

The insomnia therapeutics market covered in this report is segmented –

1) By Treatment Type: Drugs, Medical Devices

2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches

3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers

Subsegments:

1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs

2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices

What Trends Are Expected To Drive The Insomnia Therapeutics Market?

Leading companies within the insomnia therapeutics market are concentrating on the development of advanced treatments, including dual orexin receptor antagonists (DORAs), aiming to deliver specific therapeutic options with reduced adverse effects and superior safety records. A dual orexin receptor antagonist (DORA) is a type of medicine that functions by inhibiting both orexin-1 and orexin-2 receptors in the brain to facilitate sleep through the suppression of the wakefulness signaling pathway, frequently used for insomnia management. As an illustration, in June 2023, the Switzerland-based pharmaceutical company, Idorsia Pharmaceuticals Ltd., launched QUVIVIQ (daridorexant), a novel dual orexin receptor antagonist (DORA) designed for individuals with chronic insomnia disorder. This particular therapy is engineered to decrease nocturnal wakefulness without disrupting the natural sleep architecture, providing patients with improvements in sleep initiation, maintenance, and daytime performance. Its endorsement signifies a substantial progression in insomnia treatment, presenting a targeted mechanism of action that differentiates it from conventional sedative-hypnotics and addresses the existing demand for enduring, non-addictive therapeutic solutions.

Which Major Firms Are Strengthening Their Position In The Insomnia Therapeutics Industry?

Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Aurobindo Pharma, Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd, Minerva Neurosciences, Big Health, Neurovalens, Electromedical Products International Inc., Neurim Pharmaceuticals Ltd., Innovative Neurological Devices (IND), Blake Insomnia Therapeutics Inc., Cerêve Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/insomnia-therapeutics-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Insomnia Therapeutics Market?

North America was the largest region in the insomnia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Insomnia Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24255&type=smp

Browse Through More Reports Similar to the Global Insomnia Therapeutics Market 2025, By The Business Research Company

Therapeutic Dental Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795